ITMCTR1900002373尚未招募1 期
Effect of Qizhijiangtang Capsule on treating Non-Proliferative Diabetic Retinopathy
Guang'anmen Hospital, China Academy of Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 30 至 70（—）
- 性别
- All
入选标准
- •1. According to WHO criteria in 1999, meet the diagnosis of type 2 diabetes mellitus;
- •2. Meet the diagnosis of diabetic retinopathy, and the retinopathy is at non-proliferative phase;
- •3. Pattern differentiation of TCM is deficiency of qi and yin and blood stasis;
- •4. Aged 30-70 years;
- •5. Have signed the informed consent;
- •6. Hypoglycemic drugs have been used steadily in the past three months and can be expected to remain unchanged throughout the study.
排除标准
- •1. Postoperative retinal photocoagulation, suitable photocoagulation therapy, diabetic retinopathy patients with proliferative stage of diabetic retinopathy (IV, V, VI stage), diabetic retinopathy patients with type 1 diabetes mellitus, patients with other eye diseases (e.g. glaucoma, cataracts that significantly affect fundus examination, non-diabetic retinopathy, uveitis, retinal detachment) Optic nerve diseases and high myopia with fundus diseases, etc.
- •2. Those with serious complications of heart, lung, liver, kidney and brain or with other serious primary diseases;
- •3. Recurrent hypoglycemia, diabetic ketosis, ketoacidosis and severe infections in recent months;
- •4. If the systolic blood pressure is greater than 160 mmHg or (and) the diastolic blood pressure is greater than 100 mmHg after uncontrolled or controlled blood pressure;
- •5. Diabetic nephropathy occurs in renal failure (azotemia, uremia);
- •6. Pregnant, pregnant or lactating women, or those with a history of drug allergy;
- •7. Psychiatric patients;
- •8. Patients with impaired liver and kidney function (ALT and AST were 2 times higher than the upper limit of normal value, and serum creatinine was higher than the upper limit of normal value).
- •9. Alcohol abuse and/or psychoactive substances, drug abusers and addicts in the past five years;
- •10. According to the judgement of the researcher, other pathological changes or situations that reduce the possibility of enrollment or complicate the enrollment, such as frequent changes in the working environment, unstable living environment and so on, are liable to lead to lost visits;
- •11. Allergic to any component of Qizhi Jiangtang Capsule.
研究者
相似试验
尚未招募
1 期
Effect of Jiangtangxiaozhi Capsule on intestinal flora in obese IGT patientsImpaired glucose toleranceITMCTR2000003135Xiyuan Hospital,China Academy of Chinese Medical Sciences
尚未招募
4 期
A clinical study of Quanduzhong capsule in treating primary osteoporosis (kidney-yang deficiency syndrome)ITMCTR2100005285Wangjing Hospital of China Academy of Chinese Medical Sciences
尚未招募
不适用
Effect of Qianghuo Guizhi Decoction on the Treatment with Postpartum RheumatismITMCTR2000003655Shanghai Municipal Hospital of Traditional Chinese Medicine
尚未招募
4 期
Clinical study for the effect of Zhenyuan capsule on Cardiopulmonary function in patients with stable Coronary Heart Disease with Qi deficiency and Blood stasisITMCTR2000003300Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine
招募中
4 期
Efficacy and safety of Qianlieshutong capsule in the treatment of type III prostatitis (TCM syndrome of damp-heat and blood-stasis obstruction): a multicenter, randomized, double-blind, single simulation, positive drug parallel controlled clinical trialchronic prostatitisITMCTR2100004596Beijing Hospital